Physician Wealth Advisors’s Marvell Technology MRVL Stock Holding History

Physician Wealth Advisors’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155K	Buy	521 +202	+63%	+$40.5K	0.02%	250
2026 Q1	$31.6K	Sell	319 -13	-4%	-$1.09K	﹤0.01%	509
2025 Q4	$28.2K	Buy	332 +61	+23%	+$5.34K	﹤0.01%	503
2025 Q3	$22.8K	Buy	271 +107	+65%	+$7.88K	﹤0.01%	544
2025 Q2	$12.7K	Sell	164 -46	-22%	-$2.87K	﹤0.01%	607
2025 Q1	$12.9K	Buy	210 +49	+30%	+$4.75K	﹤0.01%	570
2024 Q4	$17.8K	Buy	+161	New	+$14.9K	﹤0.01%	530

Other funds holding MRVL

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

MMC

Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Physician Wealth Advisors's MRVL Position: Q2 2026 in Review

Physician Wealth Advisors increased its Marvell Technology (MRVL) stake by 63% in Q2 2026, buying an estimated $40.5K and bringing the position to 521 shares worth $155K. The position accounts for 0.02% of the portfolio, ranked #250.

Physician Wealth Advisors first reported a position in MRVL in Q4 2024 and has held it in 7 quarters since. 1,024 funds tracked by Wall St. Rank hold MRVL as of Q2 2026.

Physician Wealth Advisors held 521 shares of Marvell Technology worth $155K as of Q2 2026.
Physician Wealth Advisors bought 202 Marvell Technology shares in Q2 2026, an estimated $40.5K.
Marvell Technology made up 0.02% of Physician Wealth Advisors's portfolio in Q2 2026, its #250 holding.
Physician Wealth Advisors first reported a position in Marvell Technology in Q4 2024 and has held it in 7 quarters since.
1,024 funds tracked by Wall St. Rank held Marvell Technology as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.